Medical Devices & Tech


200 Middlesex Essex Turnpike, Ste 210
Iselin, NJ 08830 USA
Click for website

Research Sector Medical Devices & Tech

Summary Description Products to Reduce the Formation of Surgical Scar Tissue

Management Richard L. Franklin, MD, Executive Chairman; Robert P. Hickey, President & CEO, Chief Financial Officer; Eli Pines, PhD, Vice President of Research & Chief Scientific Officer; Marc R. Sportsman, Vice President of Sales; John M. Benson, CPA, Controller; Gere S. diZerega, MD, Medical Director; John S. Hoffer, Director of Quality Systems and Regulatory Affairs; Corinne Mundin, Director, International Market Development

Click here for Financial Data
Keywords: Cardiovascular, anti-adhesion, cardiology, Surgery Products, surgery, bioresorbable polymer, cardiac, heart surgery, scar tissues, adhesion, adhesions, orthopedic, spinal surgery, gynecologic surgery, general surgery, adv2007, j2008a, advamed


Updated: Dec. 11, 2013


SyntheMed is a biomaterials company engaged in the development and commercialization of anti-adhesion and drug delivery products. The company is primarily focused on the advancement and expansion of p......view more

Products / Services

Synthemed is developing a portfolio of anti-adhesion products for use in different anatomic locations, led by REPEL-CV Bioresorbable Adhesion Barrier. REPEL-CV Adhesion Barrier is a thin film designed......view more

Technology / Differentiation

Bioresorbable polymers are polymers that serve a temporary function in the body and then safely degrade into fragments which are either metabolized or eliminated via normal excretory routes. The compa...view more

Market / Customers

Adhesions are unavoidable byproducts of the trauma and bleeding that are associated with virtually all internal surgeries. They may cause such complications as infertility, bowel obstruction, chronic ......view more


The lead product, REPEL-CV, is currently marketed internationally and is awaiting FDA approval in the United States. SyntheMed has also received FDA clearance to market SinusShield Adhesion Barrier in...view more